Tiziana Life Sciences Files 6-K Report
Ticker: TLSA · Form: 6-K · Filed: Apr 16, 2026 · CIK: 0001723069
Sentiment: neutral
Topics: reporting, foreign-issuer
TL;DR
Tiziana Life Sciences filed a 6-K on 4/16/26 with a press release.
AI Summary
Tiziana Life Sciences Ltd. filed a Form 6-K on April 16, 2026, reporting as a foreign issuer. The filing includes a press release dated April 16, 2026, and associated graphic files. The company's mailing and business address is in London, England.
Why It Matters
This filing indicates ongoing reporting activity for Tiziana Life Sciences Ltd., a company operating in the pharmaceutical preparations sector.
Risk Assessment
Risk Level: low — This is a routine foreign issuer filing (6-K) and does not contain specific financial or operational news that would indicate immediate risk.
Key Players & Entities
- Tiziana Life Sciences Ltd (company) — Filer
- April 16, 2026 (date) — Filing Date and Press Release Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers which provides information that the issuer would be required to disclose to its home country security holders and that it has made or will make public.
What is the CIK number for Tiziana Life Sciences Ltd?
The CIK number for Tiziana Life Sciences Ltd is 0001723069.
What is the SIC code for Tiziana Life Sciences Ltd?
The SIC code for Tiziana Life Sciences Ltd is 2834, which corresponds to Pharmaceutical Preparations.
Where are Tiziana Life Sciences Ltd's mailing and business addresses located?
Both the mailing and business addresses for Tiziana Life Sciences Ltd are located at 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB.
What documents are included in this 6-K filing?
This 6-K filing includes a report of foreign private issuer, a press release dated April 16, 2026, and associated graphic files.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 16, 2026 regarding Tiziana Life Sciences Ltd (TLSA).